Abstract

118O Definitive results for NSCLC and bladder cancer cohorts in the phase IIa trial of visugromab (CTL-002) in advanced/metastatic anti-PD/PD-L1 relapsed/refractory solid tumors (GDFATHER-trial)

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
1208P - Safety and efficacy results of the combination of DPX-Survivac, pembrolizumab and intermittent low dose cyclophosphamide (CPA) in subjects with advanced and metastatic solid tumours: Preliminary results from the hepatocellular carcinoma (HCC), NSCLC, bladder cancer, & MSI-H cohorts
H.J Conter ... G.N Rosu
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 30
H.J Conter, et. al.H.J Conter ... G.N Rosu
01 Oct 2019
Risk of Bone Fractures Following Urinary Intestinal Diversion: A Population Based Study.
Patrick O Richard ... Ardalan Ahmad
Investigative urology | VOL. 202
Patrick O Richard, et. al.Patrick O Richard ... Ardalan Ahmad
08 Jul 2019
Histomolecular classification of urothelial carcinoma of the urinary bladder : From histological phenotype to genotype and back
Alexandra K Stoll ... Nadine Flinner
Pathologie (Heidelberg, Germany) | VOL. 45
Alexandra K Stoll, et. al.Alexandra K Stoll ... Nadine Flinner
29 Jan 2024
Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer
N Joseph ... A Choudhury
Annals of oncology : official journal of the European Society for Medical Oncology | VOL. 27
N Joseph, et. al.N Joseph ... A Choudhury
01 Feb 2016
View more papers

More From: Immuno-Oncology and Technology

Paper Title
Journal
Date
Author
Editorial Board
-
Immuno-Oncology and Technology | VOL. 22
--
01 Jun 2024
Tumor-infiltrating lymphocytes and immune-related adverse events in advanced melanoma
Isabella A.J Van Duin ... Karijn P.M Suijkerbuijk
Immuno-Oncology and Technology | VOL. -
Isabella A.J Van Duin, et. al.Isabella A.J Van Duin ... Karijn P.M Suijkerbuijk
01 Jun 2024
Regional and intratumoral adoptive T-cell therapy
Irene Olivera ... Ignacio Melero
Immuno-Oncology and Technology | VOL. -
Irene Olivera, et. al.Irene Olivera ... Ignacio Melero
01 Jun 2024
Table of Contents
-
Immuno-Oncology and Technology | VOL. 22
--
01 Jun 2024
View more papers